Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: βA phase I clinical trial of Ad5/3-Ξ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancerβ.
Elena A. Kashentseva, Igor P. Dmitriev, Karan P. Singh, Souheil Saddekni, David T. Curiel +6 more